Literature DB >> 17555867

Glucocorticoids in the control of neuroinflammation.

Denise Tischner1, Holger M Reichardt.   

Abstract

Glucocorticoids are a class of steroid hormones that are endowed with profound anti-inflammatory and immunosuppressive activities. Endogenous glucocorticoids are key players in the modulation of the immune system and establish an endocrine basis of many inflammatory diseases. In addition, synthetic glucocorticoids are amongst the most commonly prescribed drugs worldwide for the treatment of autoimmune disorders. In this review we summarize our present knowledge on the mechanisms by which glucocorticoids impact on multiple sclerosis (MS), a highly prevalent neuroinflammatory disease, and its animal model experimental autoimmune encephalomyelitis (EAE). In spite of the new methodologies that have become available during recent years, we are still far from a comprehensive picture of the mechanism by which glucocorticoids control neuroinflammation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17555867     DOI: 10.1016/j.mce.2007.03.007

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  32 in total

1.  Cerebrovascular hemodynamic changes in multiple sclerosis patients during head-up tilt table test: effect of high-dose intravenous steroid treatment.

Authors:  Zsolt Mezei; Laszlo Olah; Laszlo Kardos; Reka Katalin Kovacs; Laszlo Csiba; Tunde Csepany
Journal:  J Neurol       Date:  2013-06-12       Impact factor: 4.849

2.  Blocking stroke-induced immunodeficiency increases CNS antigen-specific autoreactivity but does not worsen functional outcome after experimental stroke.

Authors:  Christine Römer; Odilo Engel; Katarzyna Winek; Sonja Hochmeister; Tian Zhang; Georg Royl; Juliane Klehmet; Ulrich Dirnagl; Christian Meisel; Andreas Meisel
Journal:  J Neurosci       Date:  2015-05-20       Impact factor: 6.167

3.  Intranasal delivery of dexamethasone efficiently controls LPS-induced murine neuroinflammation.

Authors:  G Meneses; G Gevorkian; A Florentino; M A Bautista; A Espinosa; G Acero; G Díaz; A Fleury; I N Pérez Osorio; A Del Rey; G Fragoso; E Sciutto; H Besedovsky
Journal:  Clin Exp Immunol       Date:  2017-09-07       Impact factor: 4.330

4.  Disulfiram and Diphenhydramine Hydrochloride Upregulate miR-30a to Suppress IL-17-Associated Autoimmune Inflammation.

Authors:  Ming Zhao; Dingya Sun; Yangtai Guan; Zhihong Wang; Daoqian Sang; Mingdong Liu; Yingyan Pu; Xue Fang; Dan Wang; Aijun Huang; Xiaoying Bi; Li Cao; Cheng He
Journal:  J Neurosci       Date:  2016-08-31       Impact factor: 6.167

5.  White Matter Lesions in Femoral Head Osteonecrosis patients: Manifestation of vascular disease or not?

Authors:  A Dimitroulias; E Tsironi; G Hadjigeorgiou; N Scarmeas; Ch Rountas; A Zibis; K Malizos
Journal:  Hippokratia       Date:  2011-07       Impact factor: 0.471

6.  Ozone Therapy in Ethidium Bromide-Induced Demyelination in Rats: Possible Protective Effect.

Authors:  Neveen A Salem; Naglaa Assaf; Manal F Ismail; Yasser A Khadrawy; Mohga Samy
Journal:  Cell Mol Neurobiol       Date:  2015-10-14       Impact factor: 5.046

Review 7.  Glucocorticoid-Induced Leucine Zipper in Central Nervous System Health and Disease.

Authors:  Mythily Srinivasan; Debomoy K Lahiri
Journal:  Mol Neurobiol       Date:  2016-11-26       Impact factor: 5.590

8.  Efficacy of Different Durations of Intravenous Methylprednisolone Treatment in Relapses of Multiple Sclerosis.

Authors:  Uğur Kulu; Bedile İrem Tiftikcioğlu; Yaşar Zorlu; Mustafa Çetiner; Ufuk Şener; Gamze Tuna; Güldal Kirkali
Journal:  Noro Psikiyatr Ars       Date:  2016-03-28       Impact factor: 1.339

9.  Antiinflammatory properties of a plant-derived nonsteroidal, dissociated glucocorticoid receptor modulator in experimental autoimmune encephalomyelitis.

Authors:  Geert van Loo; Mozes Sze; Nadia Bougarne; Jelle Praet; Conor Mc Guire; Andrea Ullrich; Guy Haegeman; Marco Prinz; Rudi Beyaert; Karolien De Bosscher
Journal:  Mol Endocrinol       Date:  2009-12-04

10.  Methylprednisolone inhibits IFN-gamma and IL-17 expression and production by cells infiltrating central nervous system in experimental autoimmune encephalomyelitis.

Authors:  Zeljka Miljković; Miljana Momcilović; Djordje Miljković; Marija Mostarica-Stojković
Journal:  J Neuroinflammation       Date:  2009-12-11       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.